Weight Watchers Expands Research Partnership with American Heart Association
Event summary
- WW International is supporting the American Heart Association’s Healthy Living BEYOND Weight Study, launched on June 22, 2026.
- The study aims to understand long-term health outcomes of people living with obesity or overweight.
- WW’s integrated care model combines medical support, nutrition, and behavioral guidance for weight management.
- Internal data shows WW Med+ members using GLP-1 medications lost significantly more weight with behavioral support.
The big picture
WW’s partnership with the American Heart Association underscores the growing emphasis on real-world evidence in weight management. As cardiovascular disease remains a leading cause of death, the study could influence how obesity is treated beyond traditional weight-loss approaches. WW’s scale and data-driven insights position it as a key player in shaping future care models.
What we're watching
- GLP-1 Integration
- How WW’s ability to pair GLP-1 therapies with behavioral support will impact long-term member outcomes.
- Research Impact
- Whether the Healthy Living BEYOND Weight Study will yield actionable insights for broader weight health care.
- Member Engagement
- The pace at which WW can enroll and retain members in research initiatives to support data-driven improvements.